Wednesday, November 11, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· February 3, 2026

Stock market today: Nasdaq, S&P 500 slide as investors digest flood of tech earnings, government shutdown

View original at finance.yahoo.com
Stock market today: Nasdaq, S&P 500 slide as investors digest flood of tech earnings, government shutdown US stocks slid Tuesday investors digested a wave of tech-focused earnings, precious metals jumped to continue their wild ride, and a partial government shutdown rolled into its fourth day…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Digital assets trading volumes declined by approximately 40% quarter-on-quarter, reflecting softer client activity following record Q3

    80% confidence
  • Venezuela is uninvestable in its current state

    80% confidence
  • Remains on track to deliver 133MW of critical IT load to CoreWeave in first half of 2026

    80% confidence
  • Due to partial federal government shutdown, BLS will suspend data collection, processing, and dissemination

    80% confidence
  • JOLTS, Metropolitan Area Employment and Unemployment, and Employment Situation releases will be rescheduled upon resumption of government funding

    80% confidence
  • Raised SanDisk price target to $1,000 from $580 and maintained Outperform rating

    80% confidence
  • Walmart could benefit from tax refund provisions in the One Big Beautiful Bill Act

    80% confidence
  • US sales impact due to current prescription trends for injectable GLP-1 portfolio, intensifying competition, and negative impact from reduced obesity medication coverage in Medicaid

    80% confidence
  • Q4 loss reflects softer macro environment and lower industry trading volumes and onchain activity

    80% confidence
  • Sales decline attributed to continued volume penetration from GLP-1 treatments, market expansion in obesity, intensifying competition, and compound patent expiry of semaglutide molecule

    80% confidence
  • Received ERCOT approval for additional 830 MW of power capacity, bringing Helios total approved capacity to more than 1.6 gigawatts

    80% confidence
  • Raised Walmart price target to $130 on company's apparel strength

    80% confidence
  • The structural shortage in memory chips makes the continued growth of Samsung and SK Hynix inevitable

    80% confidence
  • Throughout 2025, NXP executed effectively despite challenging first half, maintaining operational discipline while advancing strategic priorities in software defined vehicles and physical AI

    80% confidence
  • Downplayed OpenAI investment plan of up to $100 billion

    80% confidence

Data points we hold from this source

Novo Nordisk A/S · forecast operating profit decline-5 to -13 percent
Novo Nordisk A/S · forecast sales decline-5 to -13 percent
Novo Nordisk A/S · daily stock change-14 percent
Walmart Inc. · market cap1 trillion_USD
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Biotech Catalyst Wave: Late-2026 Clinical Readouts, PDUFA Dates and Capital Restructuring
A dense cluster of Q4 2026 to Q1 2027 clinical and regulatory catalysts spans hepatitis delta (Vir's ECLIPSE/SOLSTICE), hypertension and sleep apnea (Mineralys' lorundrostat, PDUFA 2026-12-22), severe hypertriglyceridemia (plozasiran), oncology (ivonescimab BLA, PDUFA 2026-11-14) and gene therapy (Krystal). Positive data flow from AASLD and AHA presentations is offset by cost-cutting guidance, milestones slipping into 2027, and a delisting process that signals capital-market stress for some issuers. Near-term value hinges on binary FDA decisions and Phase 3 topline readouts in Q1 2027.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,564 source documents archived
Query this data → isubstrate.com
Stock market today: Nasdaq, S&P 500 slide as investors digest flood of tech earnings, government shutdown — Source | Via News | Via News